Drug Discovery Outsourcing: World Market 2011-2021

Aug 22, 2011, 06:26 ET from Reportlinker

NEW YORK, Aug. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Discovery Outsourcing: World Market 2011-2021

http://www.reportlinker.com/p0595029/Drug-Discovery-Outsourcing-World-Market-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

How will the drug discovery outsourcing market develop this decade? Our new report shows you potential revenues to 2021, discussing opportunities and prospects.

Assess the activities shaping drug discovery outsourcing worldwide. Through our research and analysis we aim to save you time and help in your decisions.

How will changes in focus for pharmaceutical R&D affect drug discovery outsourcing and contract research organisations? Which preclinical activities, technologies and national markets will provide the best opportunities from 2011 to 2021?

See potential revenues for outsourced drug discovery at total world, submarket and national levels to 2021. Find prospects for contract research providers and sponsors of early-stage pharma R&D. Our study gives data you need.

Investigate drug discovery services for chemistry and biology, including ADME and toxicity screening. Our report shows you opportunities and revenue prospects.

See discussions and revenue predictions for target identification and validation, custom synthesis, in vitro and in vivo testing, lead optimisation and high-throughput screening.

You can find activities of service providers such as Charles River Laboratories, Covance, Bridge Laboratories, Evotec, Caliper Life Sciences and WuXi AppTec. Also, you review outsourcing by Pfizer, GSK, AstraZeneca, Sanofi, Novartis and other pharma companies.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions

In our report you find revenue forecasts, growth rates and market shares. You receive a SWOT/STEP review, opinions from our survey and analysis of companies. You find 103 tables and charts and two research interviews (shown in the accompanying lists).

Drug Discovery Outsourcing: World Market 2011-2021 shows you opportunities, challenges and revenue forecasts

Our report gives you the following advantages:

• Discover revenue forecasts to 2021 for the overall world market

• Receive revenue forecasts to 2021 for submarkets, seeing growth

• Find other data for early-stage pharmaceutical R&D, viewing trends

• Analyse drug discovery from scientific, technological and commercial perspectives

• Investigate drug discovery services for a wide range of technologies

• Assess companies in drug discovery services, seeing their activities and outlooks

• Discover revenue forecasts to 2021 for the US, Canada, the UK, Germany, France, Spain, Italy, Japan, China and India

• Assess competition and opportunities that will influence revenues

• See what will stimulate and restrain the industry and market from 2011

• Investigate commercial requirements, identifying opportunities

• Analyse opportunities and challenges for established and emerging companies

• View opinions from two interviews with authorities on the industry.

There, you find a distinctive mix of quantitative and qualitative analysis with original predictions. We tackle crucial questions in drug discovery outsourcing, helping you to stay ahead.

Order our report now to gain industry and market analysis for drug discovery services

Our report is for everybody interested in industry and market analysis for early-stage pharma R&D. Find trends and answers. Don't miss out - please order our report now.

Table of Contents

1. Executive Summary

1.1 Review of the Global Drug Discovery Outsourcing Market

1.2 Aims, Scope and Format of Report

1.3 Research and Analysis Methods

2. Drug Discovery Outsourcing

2.1 Introduction to Drug Discovery Outsourcing

2.2 Reasons for Outsourcing Pharmaceutical Drug Discovery Operations

2.2.1 Cost Pressures

2.2.2 Focus on Core Competencies

2.2.3 Reductions in the Time-to-Market

2.2.4 Outsourcing Can Help Foster Strategic Partnerships

2.3 Which Pharmaceutical Functions Are Typically Outsourced to CROs?

2.4 The Increasing Emphasis in Outsourcing Indicates a Shift from the Blockbuster Model to a More Distributed Model of Drug Development

2.5 Academic Laboratories are Well-Equipped to Perform Certain Aspects of Early Drug Discovery Research

2.6 Projects for Outsourcing are Increasingly Going to Asia

2.7 Pharma Resource Sharing Could be a Future Trend that Restrains Growth in the Global CRO Market

2.8 For CROs the Quality of Service at Each Stage is More Important than the Spectrum of Services Offered

2.9 Drug Discovery Outsourcing by the Pharmaceutical Industry

2.9.1 Introduction

2.9.2 Pfizer

2.9.3 Johnson & Johnson

2.9.4 GlaxoSmithKline

2.9.5 Sanofi

2.9.6 Novartis

2.9.7 AstraZeneca

2.9.8 Roche

2.9.9 Abbott Laboratories

2.9.10 Eli Lilly

2.9.11 Bristol-Myers Squibb

3. Companies Providing Drug Discovery Services

3.1 Introduction

3.2 Key Attributes of a Successful Contract Research Organisation (CRO)

3.2.1 Competitive Cost Structure

3.2.2 Strong Scientific Skill Set

3.2.3 Excellent Turnaround Times and Good Communication

3.2.4 Respect for Intellectual Property Rights

3.2.5 Excellent Working Relationship with Innovator Companies

3.3 Leading Companies Offering Drug Discovery Services, 2011

3.3.1 Introduction

3.3.2 Charles River Laboratories

3.3.3 Covance

3.3.4 Bridge Laboratories

3.3.5 Evotec

3.3.6 Caliper Life Sciences

3.3.7 Apredica

3.3.8 WuXi AppTec

4. Summary of the Drug Discovery Outsourcing Market, 2011-2021

4.1 Overview of the Drug Discovery Outsourcing Market, 2011-2021

4.2 Service Sectors and Drivers of Drug Discovery Outsourcing, 2011-2021

4.3 Long-Term Contracts and Strategic Outsourcing to CROs

4.4 Strategic Alliances with Non-Profit and Academic Laboratories

5. Global Drug Discovery Outsourcing Market, 2011-2021

5.1 The Global Drug Discovery Outsourcing Market, 2010

5.2 The Global Drug Discovery Outsourcing Market, 2010-2015

5.3 The Global Drug Discovery Outsourcing Market, 2016-2021

5.4 Key Services Outsourced to Contract Research Organisations, 2010

5.4.1 Outsourcing Chemistry Services Remains Popular

5.5 Key Services Outsourced to Contract Research Organisations, 2010-2015

5.6 Key Services Outsourced to Contract Research Organisations, 2016-2021

5.7 Global Chemistry Outsourcing Market, 2011-2021

5.7.1 Introduction

5.7.2 Global Market for Outsourcing ADME/Tox Screens, 2010-2021

5.7.3 Global Market for Outsourcing In Vitro Testing, 2010-2021

5.7.4 Global Market for Outsourcing Custom Synthesis Requirements, 2010-2021

5.8 Global Biology Outsourcing Market, 2011-2021

5.8.1 Introduction

5.8.2 The Target Identification and Validation Market, 2010-2021

5.8.3 In Vivo Testing Market, 2010-2021

5.9 Global Market for Lead Optimisation, 2011-2021

5.10 Global Market for High-Throughput Screening, 2011-2021

6. Leading National Markets for Outsourcing Activities, 2011-2021

6.1 The Global Drug Discovery Outsourcing Market, 2010

6.2 Forecasts for the Leading National Markets for Drug Discovery Outsourcing, 2010-2021

6.2.1 The US Drug Discovery Outsourcing Market, 2010-2021

6.2.2 The Canadian Drug Discovery Outsourcing Market, 2010-2021

6.2.3 The UK Drug Discovery Outsourcing Market, 2010-2021

6.2.4 Other European Drug Discovery Outsourcing Markets, 2010-2021

6.2.5 The Japanese Drug Discovery Outsourcing Market, 2010-2021

6.2.6 The Chinese Drug Discovery Outsourcing Market, 2010-2021

6.2.7 The Indian Drug Discovery Outsourcing Market, 2010-2021

7. SWOT Analysis of the Drug Discovery Outsourcing Market, 2011-2021

7.1 SWOT Analysis of the Drug Discovery Outsourcing Market

7.2 Drivers for the Drug Discovery Outsourcing Market

7.2.1 Reductions in the Cost of Drug Discovery Operations

7.2.2 Outsourcing Offers Completion of Projects with Good Turnaround Times

7.2.3 Technological Advances in Genomic and Proteomic Instrumentation

7.3 Restraints for the Drug Discovery Outsourcing Market

7.3.1 Some CROs Offer Service Ranges without Clear Market Differentiation

7.3.2 Reduction in Pharma R&D is a Double-Edged Sword for the CRO Industry

7.3.3 Increasing Outsourcing of Drug Discovery Services to Academic Laboratories

7.4 Outlook for the Drug Discovery Outsourcing Market

7.4.1 More R&D Functions Will Be Outsourced to Asia and Central and Eastern Europe (CEE)

7.4.2 Asia Will Provide the Muscle but Where Will the Innovation Come From?

7.4.3 The Increasing Incidence of Drug Counterfeiting Will Act as a Restraint on the Global Drug Discovery Outsourcing Market

8. Research Interviews

8.1 Dr Katya Tsaioun, Chief Scientific Offer, Cyprotex, USA

8.1.1 Contract Research Services Offered by Cyprotex

8.1.2 The Advantages of Contracting Out Services

8.1.3 Therapeutic Areas

8.1.4 Technological Platforms Used

8.1.5 Future Plans to Expand Services?

8.1.6 The Future of Drug Discovery Outsourcing

8.1.7 Final Thoughts

8.2 Dr David Moskowitz, Chairman, CEO and Chief Medical Officer, GenoMed, Florida, USA

8.2.1 The Work of GenoMed

8.2.2 The Importance of Strategic Alliances for Drug Discovery

8.2.3 Translational Medicine and the Role of Genomics

8.2.4 Current Pharmaceutical R&D Model and the Future of Drug Discovery

8.2.5 Outlook for GenoMed

9. Conclusions

9.1 Drug Discovery Outsourcing Will Continue to Expand, 2011-2021

9.2 The Resurgence of Public-Private Partnerships Will Restrain Growth in the Drug Discovery Outsourcing Market

9.3 Trend of Outsourcing to Asia Will Continue

List of Tables

Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2011

Table 3.1 Leading Contract Research Organisations, 2011

Table 4.1 Summary of the Global Drug Discovery Outsourcing Market ($bn), 2011-2021

Table 4.2 Summary of the Global Chemistry Outsourcing Market ($bn), 2011-2012

Table 4.3 Summary of the Global Biology Outsourcing Market ($bn), 2011-2021

Table 4.4 Summary of the Global High-Throughput Screening and Lead Optimisation Markets ($bn), 2011-2021

Table 5.1 Global Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 5.2 Global Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 5.3 Global Revenues ($bn) and Market Shares (%) for the Drug Discovery Services (%) Offered by Contract Research Organisations, 2010

Table 5.4 Global Revenues ($bn) and Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2010-2015

Table 5.5 Global Revenues ($bn) and Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2016-2021

Table 5.6 Market Shares (%) for Chemistry Services Typically Outsourced to CROs, 2010-2015

Table 5.7 Market Shares (%) for Chemistry Services Typically Outsourced to CROs, 2016-2021

Table 5.8 Global Revenues ($bn) for Outsourcing ADME/Tox Screens, 2010-2015

Table 5.9 Global Revenues ($bn) for Outsourcing ADME/Tox Screens, 2016-2021

Table 5.10 Global Revenues ($bn) for Outsourcing In Vitro Testing, 2010-2015

Table 5.11 Global Revenues ($bn) for Outsourcing In Vitro Testing, 2016-2021

Table 5.12 Global Revenues ($bn) for Custom Synthesis Services, 2010-2015

Table 5.13 Global Revenues ($bn) for Custom Synthesis Services, 2016-2021

Table 5.14 Market Shares (%) for Biology Services Outsourced to CROs, 2010-2015

Table 5.15 Market Shares (%) for Biology Services Outsourced to CROs, 2016-2021

Table 5.16 Revenues ($bn) for the Target Identification and Validation Market, 2010-2015

Table 5.17 Revenues ($bn) for the Target Identification and Validation Market, 2016-2021

Table 5.18 Revenues ($bn) for the In Vivo Testing Market, 2010-2015

Table 5.19 Revenues ($bn) for the In Vivo Testing Market, 2016-2021

Table 5.20 Global Revenues ($bn) for Outsourcing Lead Optimisation, 2010-2015

Table 5.21 List of CROs Providing Lead Optimisation Services, 2011

Table 5.22 List of CROs (Continued) Providing Lead Optimisation Services, 2011

Table 5.23 Global Revenues ($bn) for Outsourcing Lead Optimisation, 2016-2021

Table 5.24 Global Revenues ($bn) for Outsourcing High-Throughput Screening, 2010-2015

Table 5.25 Global Revenues ($bn) for Outsourcing High-Throughput Screening, 2016-2021

Table 6.1 Total Revenues ($bn) Generated from Drug Discovery Outsourcing Activities Relative to Country of Origin for Outsourcing, 2010

Table 6.2 Total Revenues ($bn) Generated from Drug Discovery Outsourcing Activities Relative to Country of Origin for Outsourcing, 2010-2015

Table 6.3 Total Revenues ($bn) Generated from Drug Discovery Outsourcing Activities Relative to Country of Origin for Outsourcing, 2016-2021

Table 6.4 National Market Shares (%) for the Global Drug Discovery Outsourcing Market, 2010-2021

Table 6.5 The US Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.6 The US Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 6.7 The Canadian Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.8 The Canadian Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 6.9 The UK Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.10 The UK Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 6.11 Other European Markets ($bn) for Drug Discovery Outsourcing, 2010-2015

Table 6.12 Other European Markets ($bn) for Drug Discovery Outsourcing, 2016-2021

Table 6.13 The Japanese Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.14 The Japanese Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 6.15 The Chinese Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.16 The Chinese Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 6.17 The Indian Drug Discovery Outsourcing Market ($bn), 2010-2015

Table 6.18 The Indian Drug Discovery Outsourcing Market ($bn), 2016-2021

Table 7.1 SWOT Analysis of the World Drug Discovery Outsourcing Market, 2011

Table 7.2 Selected Asian CROs and Their Total Number of Full-Time Employees, 2011

Table 9.1 Key Sectors in the Global Drug Discovery Outsourcing Market ($bn),

2011, 2013, 2015, 2017, 2019 and 2021

List of Figures

Figure 2.1 Typical Stages of the Drug Development Cycle, 2011

Figure 3.1 Number of Employees in Leading Contract Research Organisations, 2011

Figure 4.1 Summary of the Global Drug Discovery Outsourcing Market ($bn), 2011-2021

Figure 5.1 Global Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 5.2 Global Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 5.3 Global Revenues ($bn) for the Drug Discovery Services Offered by Contract Research Organisations, 2010

Figure 5.4 Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2010

Figure 5.5 Global Revenues ($bn) for the Drug Discovery Services Offered by Contract Research Organisations, 2010-2015

Figure 5.6 Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2015

Figure 5.7 Global Revenues ($bn) for the Drug Discovery Services Offered by Contract Research Organisations, 2016-2021

Figure 5.8 Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2016

Figure 5.9 Market Shares (%) for the Drug Discovery Services Offered by Contract Research Organisations, 2021

Figure 5.10 Market Shares (%) for Chemistry Services Outsourced to CROs, 2010

Figure 5.11 Market Shares (%) for Chemistry Services Outsourced to CROs, 2015

Figure 5.12 Market Shares (%) for Chemistry Services Outsourced to CROs, 2021

Figure 5.13 Global Revenues ($bn) for Outsourcing ADME/Tox Screens, 2010-2015

Figure 5.14 Global Revenues ($bn) for Outsourcing ADME/Tox Screens, 2016-2021

Figure 5.15 Global Revenues ($bn) for Outsourcing In Vitro Testing, 2010-2015

Figure 5.16 Global Revenues ($bn) for Outsourcing In Vitro Testing, 2016-2021

Figure 5.17 Global Revenues ($bn) for Custom Synthesis Services, 2010-2015

Figure 5.18 Global Revenues ($bn) for Custom Synthesis Services, 2016-2021

Figure 5.19 Market Shares (%) for Biology Services Outsourced to CROs, 2010

Figure 5.20 Market Shares (%) for Biology Services Outsourced to CROs, 2015

Figure 5.21 Market Shares (%) for Biology Services Outsourced to CROs, 2021

Figure 5.22 Revenues ($bn) for the Target Identification and Validation Market, 2010-2015

Figure 5.23 Revenues ($bn) for the Target Identification and Validation Market, 2016-2021

Figure 5.24 Revenues ($bn) for the In Vivo Testing Market, 2010-2015

Figure 5.25 Revenues ($bn) for the In Vivo Testing Market, 2016-2021

Figure 5.26 Global Revenues ($bn) for Outsourcing Lead Optimisation, 2010-2015

Figure 5.27 Global Revenues ($bn) for Outsourcing Lead Optimisation, 2016-2021

Figure 5.28 Global Revenues ($bn) for Outsourcing High-Throughput Screening, 2010-2015

Figure 5.29 Global Revenues ($bn) for Outsourcing High-Throughput Screening, 2016-2021

Figure 6.1 Total Revenues ($bn) Generated from Drug Discovery Outsourcing Activities Relative to Country of Origin for Outsourcing, 2010

Figure 6.2 National Market Shares (%) for the Global Drug Discovery Outsourcing Market, 2010

Figure 6.3 National Market Shares (%) for the Global Drug Discovery Outsourcing Market, 2015

Figure 6.4 National Market Shares (%) for the Global Drug Discovery Outsourcing Market, 2021

Figure 6.5 The US Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.6 The US Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 6.7 The Canadian Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.8 The Canadian Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 6.9 The UK Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.10 The UK Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 6.11 Other European Markets ($bn) for Drug Discovery Outsourcing, 2010-2015

Figure 6.12 Other European Markets ($bn) for Drug Discovery Outsourcing, 2016-2021

Figure 6.13 The Japanese Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.14 The Japanese Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 6.15 The Chinese Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.16 The Chinese Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 6.17 The Indian Drug Discovery Outsourcing Market ($bn), 2010-2015

Figure 6.18 The Indian Drug Discovery Outsourcing Market ($bn), 2016-2021

Figure 9.1 Key Sectors in the Global Drug Discovery Outsourcing Market ($bn), 2011, 2013, 2015, 2017, 2019 and 2021

Companies Listed

Abbott Diagnostics

Abbott Laboratories

Advinus

Advion BioServices

AMRI

Andromeda Biotech

Apredica

Aptuit

Argenta Discovery

Asclepia

Asinex

Asis Chem

AstraZeneca

Aurigene

Axxam

BGI

BioDura

BioFocus

Boehringer Ingelheim

Bridge Laboratories

Bristol-Myers Squibb

Caliper Discovery Alliances & Services (CDAS)

Caliper Life Sciences

Cayman Chemical

Cellomics

Cellumen

Charles River Laboratories

Charnwood Molecular

CHDI

Chembiotek

ChemBridge

Chemison

ChemoOvation

ChemPartner

Covance

CreaGen Biosciences

Crown Bioscience

Cyprotex

Dalton Pharma Services

DiscoveRx

Domainex

Elexopharm

Eli Lilly

Ennova Medchem

Epichem

European Commission

Evotec

Exelgen Discovery

Food and Drug Administration (US FDA)

Galapagos

Genentech

GenoMed

Genpact

GenScript

GlaxoSmithKline

GVK BIO

IBM

Icon

Idealp Pharma

Industrial Research

iNovacia

iThemba Pharmaceuticals

Johnson & Johnson

Jubilant Biosys

Jubilant Organosys

Kalexsyn

Medicilon

MedImmune

Nanosyn

National Institutes of Health

Nature Reviews Drug Discovery

NIH-FDA Leadership Council

Nikem Research

Novartis

NovaScreen Biosciences

Novo Nordisk

O2h

Ono Pharmaceutical

Pacific World Discovery

Parexel

Peakdale Molecular

Peptech

Pfizer

Pharmaceutical Security Institute

Pharmaron

Pharmidex

Polyphor

PPD

PRA

PRECOS

Prestwick Chemical

Provid Pharmaceuticals

ProXyChem

Purdue Research Park

Pyxis Discovery

Qiagen

Quintiles

Ricerca Biosciences

Roche

Roche R&D Center China (RRDCC)

Sage Bionetworks

Sanofi

Scottish Biomedical

SCYNEXIS

Selcia

Structural Genomics Consortium

Sygnature

SYN|thesis Med Chem

Syngene

Synthetic Genomics Vaccines

Tata Consulting Services

Teva Pharmaceutical Industries

Thermo Fisher Scientific

United States Government

University of North Carolina

University of Oxford

University of Toronto

Wellcome Trust

World Customs Organization (WCO)

World Health Organization (WHO)

WuXi AppTec

To order this report:

Drug Discovery and Development Industry: Drug Discovery Outsourcing: World Market 2011-2021

Drug Discovery and Development Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com